Translational and Clinical Aspects of Metabolic, Anabolic and Endothelial Dysfunction in Heart Failure

NCT05277415 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2024-10-23

No results posted yet for this study

Summary

In patients with HF cardiac output, metabolism and endothelial function will be studied during and after treatment with ghrelin infusion

Conditions

  • Heart Failure With Reduced Ejection Fraction HFrEF

Interventions

BIOLOGICAL

Ghrelin

Ghrelin infusion

BIOLOGICAL

Placebo

Placebo

Sponsors & Collaborators

  • Lars Lund

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-17
Primary Completion
2014-05-22
Completion
2014-05-22

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05277415 on ClinicalTrials.gov